Cargando…
Thrombopoietin participates in platelet activation in COVID-19 patients
BACKGROUND: The pathogenesis of coronavirus disease 2019 (COVID-19) is characterized by enhanced platelet activation and diffuse hemostatic alterations, which may contribute to immunothrombosis/thromboinflammation and subsequent development of target-organ damage. Thrombopoietin (THPO), a growth fac...
Autores principales: | Lupia, Enrico, Capuano, Marialessia, Vizio, Barbara, Schiavello, Martina, Bosco, Ornella, Gelardi, Maria, Favale, Edoardo, Pivetta, Emanuele, Morello, Fulvio, Husain, Shahid, Keshavjee, Shaf, Del Sorbo, Lorenzo, Montrucchio, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556163/ https://www.ncbi.nlm.nih.gov/pubmed/36242922 http://dx.doi.org/10.1016/j.ebiom.2022.104305 |
Ejemplares similares
-
Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus
por: Bosco, Ornella, et al.
Publicado: (2021) -
Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
por: Schiavello, Martina, et al.
Publicado: (2023) -
Thrombopoietin as Biomarker and Mediator of Cardiovascular Damage in Critical Diseases
por: Lupia, Enrico, et al.
Publicado: (2012) -
Platelets and Multi-Organ Failure in Sepsis
por: Greco, Elisabetta, et al.
Publicado: (2017) -
Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: Vizio, Barbara, et al.
Publicado: (2021)